homocysteine has been researched along with Fracture, Pathologic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iwamoto, J | 1 |
| Iwamoto, J; Kanoko, T; Sato, Y; Satoh, K | 1 |
1 review(s) available for homocysteine and Fracture, Pathologic
| Article | Year |
|---|---|
[Effects of SERMs on bone health. Discrimination of SERMs from bisphosphonates in the treatment of postmenopausal osteoporosis].
Topics: Biomarkers; Bone Density Conservation Agents; Diphosphonates; Female; Fractures, Spontaneous; Homocysteine; Humans; Osteoporosis, Postmenopausal; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Retrospective Studies; Selective Estrogen Receptor Modulators; Spinal Fractures | 2010 |
1 other study(ies) available for homocysteine and Fracture, Pathologic
| Article | Year |
|---|---|
RETRACTED: Homocysteine as a predictive factor for hip fracture in elderly women with Parkinson's disease.
Topics: Accidental Falls; Aged; Antiparkinson Agents; Cohort Studies; Female; Follow-Up Studies; Fractures, Spontaneous; Hip Fractures; Homocysteine; Humans; Hyperhomocysteinemia; Immobilization; Incidence; Japan; Levodopa; Osteoporosis; Parkinson Disease; Proportional Hazards Models; Risk Factors | 2005 |